Search results
Showing 4111 to 4125 of 9010 results
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies
Help make a difference on behalf of the people most affected by our recommendations on our voluntary and community sector forum.
Membership details, terms of reference, future meeting dates and past meeting minutes for our diagnostics advisory committee.
Our forward view highlights the areas we will prioritise in the coming year.
Getting involved as a voluntary and community sector organisation
Getting involved with NICE as a voluntary and community sector organisation
Our board meetings are open to the public. You can download the agenda, papers and minutes for each meeting.
Our events help you meet experts and stay connected with peers.
Read the biographies for all members of the NICE antimicrobial evaluation committee.
Details and meeting dates of the antimicrobial evaluation panel
Our board sets out our strategic priorities and policies. It has 2 sub-committees, the audit and risk assurance committee and the remuneration committee.
NICE's guidance executive is made up of executive directors, guidance centre directors and senior team members.
This document describes a real-world evidence framework that aims to improve the quality of real-world evidence informing our guidance. The framework does not set minimum standards for the acceptability of evidence. The framework is mainly targeted at those developing evidence to inform NICE guidance. It is also relevant to patients, those collecting data, and reviewers of evidence
The EQ-5D is a short questionnaire used to understand how a person’s health affects their quality of life. It is used in health research and to help inform decisions about healthcare treatments.
NICE has implemented new measures to evaluate the cost-effectiveness of medicines, following a policy change that aims to give patients improved access to treatments. This follows the government’s decision to increase the thresholds that NICE can use in technology appraisals to £25,000 to £35,000 per quality-adjusted life year gained.
The NICE commercial liaison team aim to reduce the workload for the NHS and frontline staff by making commercial agreements more straightforward.